(Q46075799)

19 December 2017

title

Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma (English)

1 reference

19 December 2017

author

Giovanni Paganelli

10

1 reference

19 December 2017

author name string

Mirco Bartolomei

1

1 reference

19 December 2017

Lisa Bodei

2

1 reference

19 December 2017

Concetta De Cicco

3

1 reference

19 December 2017

Chiara Maria Grana

4

1 reference

19 December 2017

Marta Cremonesi

5

1 reference

19 December 2017

Edoardo Botteri

6

1 reference

19 December 2017

Silvia Melania Baio

7

1 reference

19 December 2017

Demetrio Aricò

8

1 reference

19 December 2017

Maddalena Sansovini

9

1 reference

19 December 2017

publication date

25 March 2009

1 reference

19 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

19 December 2017

volume

36

1 reference

19 December 2017

issue

9

1 reference

19 December 2017

page(s)

1407-1416

1 reference

19 December 2017

The WHO classification of tumors of the nervous system

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1115-Z

Benign meningiomas: primary treatment selection affects survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1115-Z

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1115-Z

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1115-Z

Neuroendocrine tumors and somatostatin: imaging techniques

21 January 2018

1 reference

12 December 2020

Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma

1 reference

12 December 2020

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

1 reference

12 December 2020

Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth

1 reference

12 December 2020

In vitro detection of somatostatin receptors in human tumors

1 reference

12 December 2020

High incidence of somatostatin receptors in human meningiomas: biochemical characterization

1 reference

12 December 2020

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

1 reference

12 December 2020

Multiple meningiomas: a clinical, surgical, and cytogenetic analysis

1 reference

12 December 2020

Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas

1 reference

12 December 2020

90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies

1 reference

12 December 2020

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

1 reference

12 December 2020

The recurrence of intracranial meningiomas after surgical treatment

1 reference

12 December 2020

Identification by fluorescence of the G chromosome lost in human meningomas.

1 reference

12 December 2020

Diagnosis and treatment of atypical and anaplastic meningiomas: a review

1 reference

12 December 2020

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

1 reference

12 December 2020

Dosimetry in Peptide radionuclide receptor therapy: a review.

1 reference

12 December 2020

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue

1 reference

12 December 2020

Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas

1 reference

12 December 2020

Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma

1 reference

12 December 2020

Relationship between malignant subtypes of meningioma and clinical outcome.

1 reference

12 December 2020

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

1 reference

12 December 2020

Novel therapies for meningiomas

1 reference

12 December 2020

Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.

1 reference

12 December 2020

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome

1 reference

12 December 2020

Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

1 reference

12 December 2020

Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases

1 reference

12 December 2020

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy

1 reference

12 December 2020

Radiation-induced head and neck tumours

1 reference

12 December 2020

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

1 reference

12 December 2020

Postradiation meningioma in a child.

1 reference

12 December 2020

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

1 reference

12 December 2020

Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.

1 reference

12 December 2020

The value of radiation therapy as an adjuvant to surgery in intracranial meningiomas

1 reference

12 December 2020

Meningioma: analysis of recurrence and progression following neurosurgical resection

1 reference

12 December 2020

Hormones, radiosurgery and virtual reality: new aspects of meningioma management.

1 reference

12 December 2020

Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique.

1 reference

12 December 2020

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

12 December 2020

The Meningioma Controversy: Postoperative radiation therapy

1 reference

12 December 2020

Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma

1 reference

12 December 2020

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

1 reference

12 December 2020

10.1007/S00259-009-1115-Z

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017